These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 82772)

  • 61. Can Wilson's disease patients be decoppered?
    Mason J; McQuaid A; Pheiffer H
    Lancet; 1989 Jun; 1(8652):1455. PubMed ID: 2567467
    [No Abstract]   [Full Text] [Related]  

  • 62. Effective treatment of Wilson's disease with oral zinc.
    Hoogenraad TU
    Arch Neurol; 1982 Oct; 39(10):672. PubMed ID: 7125987
    [No Abstract]   [Full Text] [Related]  

  • 63. Defective biliary excretion of copper in Wilson's disease.
    Frommer DJ
    Gut; 1974 Feb; 15(2):125-9. PubMed ID: 4820637
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Copper deficiency in Wilson's disease: peripheral neuropathy and myelodysplastic syndrome complicating zinc treatment.
    Cortese A; Zangaglia R; Lozza A; Piccolo G; Pacchetti C
    Mov Disord; 2011 Jun; 26(7):1361-2. PubMed ID: 21449011
    [No Abstract]   [Full Text] [Related]  

  • 65. [Current principles of Wilson's disease--diagnosis and treatment].
    Najda J; Stella-Hołowiecka B; Machalski M; Woszczyk D; Mykała-Cieśla J
    Wiad Lek; 2002; 55(9-10):600-7. PubMed ID: 12607416
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Copper dynamics in Wilson's disease.
    Osborn SB; Walshe JM; Williams R
    Ann Biol Clin (Paris); 1972; 30(4):391-6. PubMed ID: 5082973
    [No Abstract]   [Full Text] [Related]  

  • 67. Molecular genetics and zinc-copper interactions in human Wilson's disease and canine copper toxicosis.
    Brewer GJ; Yuzbasiyan-Gurkan V; Lee DY
    Prog Clin Biol Res; 1993; 380():129-45. PubMed ID: 8456122
    [No Abstract]   [Full Text] [Related]  

  • 68. Use of the stable isotope 65Cu test for the screening of Wilson's disease in a family with two affected members.
    Merli M; Patriarca M; Loudianos G; Valente C; Riggio O; De Felice G; Petrucci F; Caroli S; Attili AF
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):270-5. PubMed ID: 9759594
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Copper toxicity, rats and Wilson's disease.
    Nutr Rev; 1975 Feb; 33(2):51-3. PubMed ID: 1124157
    [No Abstract]   [Full Text] [Related]  

  • 70. Oral zinc sulphate for Wilson's disease.
    Van Caillie-Bertrand M; Degenhart HJ; Visser HK; Sinaasappel M; Bouquet J
    Arch Dis Child; 1985 Jul; 60(7):656-9. PubMed ID: 4026362
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Pathogenesis and treatment of Wilson's disease].
    Nagy J; Vincze Z; Folhoffer A; Horváth A; Csák T; Zelkó R
    Acta Pharm Hung; 2003; 73(4):237-41. PubMed ID: 15279036
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Recovery after copper-deficiency myeloneuropathy in Wilson's disease.
    Teodoro T; Neutel D; Lobo P; Geraldo AF; Conceição I; Rosa MM; Albuquerque L; Ferreira JJ
    J Neurol; 2013 Jul; 260(7):1917-8. PubMed ID: 23712800
    [No Abstract]   [Full Text] [Related]  

  • 73. Wilson's disease: clinical management and therapy.
    Brewer GJ; Askari FK
    J Hepatol; 2005; 42 Suppl(1):S13-21. PubMed ID: 15777568
    [No Abstract]   [Full Text] [Related]  

  • 74. Localization of Cu64 in serum fractions following oral administration: an alteration in Wilson's disease.
    BEARN AG; KUNKEL HG
    Proc Soc Exp Biol Med; 1954 Jan; 85(1):44-8. PubMed ID: 13134284
    [No Abstract]   [Full Text] [Related]  

  • 75. [Copper in the feces--a marker for the effectiveness of zinc in the treatment of Wilson's disease].
    Dastych M
    Z Gastroenterol; 1990 Aug; 28(8):389-91. PubMed ID: 2275259
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Introduction. Symposium on copper metabolism and Wilson's disease.
    Goldstein NP; Owen CA
    Mayo Clin Proc; 1974 Jun; 49(6):363-7. PubMed ID: 4599351
    [No Abstract]   [Full Text] [Related]  

  • 77. Wilson's disease (hepatolenticular degeneration) of late adult onset: report of case.
    Fitzgerald MA; Gross JB; Goldstein NP; Wahner HW; McCall JT
    Mayo Clin Proc; 1975 Aug; 50(8):438-42. PubMed ID: 1152537
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Current and future therapy in haemochromatosis and Wilson's disease.
    Murray KF; Lam D; Kowdley KV
    Expert Opin Pharmacother; 2003 Dec; 4(12):2239-51. PubMed ID: 14640923
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Zinc in the treatment of Wilson's disease: how it works.
    Friedman LS; Yarze JC
    Gastroenterology; 1993 May; 104(5):1566-8. PubMed ID: 8482474
    [No Abstract]   [Full Text] [Related]  

  • 80. Normal manganese turnover in Wilson's disease.
    Peterson DI; Oldendorf WH; Lederer M
    Proc Soc Exp Biol Med; 1969 May; 131(1):20-2. PubMed ID: 5770104
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.